Intrinsiqs

Is BridgeBio Pharma, Inc. overvalued?

BridgeBio Pharma, Inc. (BBIO) — key valuation metrics and fundamentals.

No verdict
Price
$71.88
Fair value
Current P/E
Normal P/E
Market cap
$14.00B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares BBIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.